Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Lipidor AB | 4,949,200 | net | 28 Jun 2024 | tx 3+4,949,200 |
| Asarina Pharma AB | 104,000 | net | 28 May 2021 | tx 2+104,000 |
| Nanexa AB | 300 | net | 27 Feb 2020 | tx 1+300 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 28 Jun 2024 | PURCHASE | Lipidor AB | 3,159,360 | 0.05 SEK | |
| 28 Jun 2024 | PURCHASE | Lipidor AB | 1,289,840 | 0.00 SEK | deriv |
| 12 Jun 2024 | PURCHASE | Lipidor AB | 500,000 | 0.20 SEK | first after silence |
| 28 May 2021 | PURCHASE | Asarina Pharma AB | 94,000 | 0.53 SEK | derivfirst after silence |
| 27 Feb 2020 | PURCHASE | Nanexa AB | 300 | 30.00 SEK | first after silence |
| 18 Sept 2018 | PURCHASE | Asarina Pharma AB | 10,000 | 21.00 SEK |
3 purchases reported after at least 12 months of silence — most recent on 12 Jun 2024.